Milestone Scientific Inc. (AMEX:MLSS) was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Friday.

Separately, Maxim Group reiterated a “buy” rating and issued a $4.00 price target on shares of Milestone Scientific in a research note on Tuesday, June 13th.

Milestone Scientific (AMEX:MLSS) traded up 4.00% during midday trading on Friday, reaching $1.30. The company had a trading volume of 2,794 shares. The company’s market capitalization is $42.89 million. The firm has a 50-day moving average of $1.25 and a 200 day moving average of $1.38. Milestone Scientific has a 1-year low of $1.08 and a 1-year high of $2.40.

TRADEMARK VIOLATION NOTICE: “Milestone Scientific Inc. (MLSS) Upgraded to “Hold” at ValuEngine” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/09/milestone-scientific-inc-mlss-upgraded-to-hold-at-valuengine.html.

Milestone Scientific Company Profile

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.